- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00991809
Study on the Development of Opioid Induced Hyperalgesia (OIH) After Exposure to Alfentanil (0813)
September 7, 2017 updated by: Johns Hopkins University
A Pilot Study of Prolonged, Intermittent Exposure to Alfentanil on Opioid-Induced Hyperalgesia in Healthy Volunteers
The purpose of this study was to follow a person's response to experimental pain after multiple consecutive exposures to alfentanil or diphenhydramine to see if the person can tolerate the pain more, less, or the same at the end of the study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This project investigates the phenomenon of opioid-induced hyperalgesia (OIH).
Opioid analgesics, in addition to their therapeutic anti-nociceptive effects, under some conditions produce pro-nociceptive effects.
This phenomenon of pain or pain sensitivity being increased by prior opioid administration is called opioid-induced hyperalgesia.
It is thought to be relevant both to pain management complications and to complications of opioid dependence and its treatment.
This study investigated the time-course of opioid-induced hyperalgesia development in healthy normal volunteers (N=12 completers), using a series of acute alfentanil administrations (15 mg/kg mg intramuscular (IM) per day) spaced at 3-4 day intervals, with testing for pain tolerance using the cold pressor test (CPT), and mechanical quantitative sensory testing (MQST) each administered repeatedly over time within each testing day.
The goal was to determine the time course of OIH development following acute opioid administration, and to assess whether this changes over repeated acute opioid administrations.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- Behavioral Pharmacology Research Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Age 18-55
- No active medical conditions
- BMI between 20-30
- Able and willing to perform/tolerate pain procedures
- Able to communicate in English
Exclusion Criteria:
- Lifetime substance use disorder, except for alcohol abuse/dependence in remission
- Use of opiates in last 3 months
- Ongoing marijuana use
- Acute or chronic pain
- Neurologic or psychiatric condition known to influence cold pressor testing (peripheral neuropathy, major depression, or schizophrenia)
- Current use of prescribed or over the counter pain medications
- Previous adverse reaction to opiate medications or diphenhydramine
- Use of tobacco or caffeine on study days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Alfentanil
Subjects received a series of acute alfentanil administrations each session (15 mcg/kg IM per session), with sessions spaced at 3-4 day intervals.
|
15 mcg/kg IM
|
Active Comparator: Diphenhydramine
Subjects received a series of acute diphenhydramine administrations each session (25 mg IM per session), with sessions spaced at 3-4 day intervals.
|
25 mg IM
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Tolerance
Time Frame: 8 sessions over 4-6 weeks
|
The participant places their hand in a water bath kept at 4 degrees Celsius (cold pressor test).
They then continue to hold the hand in the water bath until they can no longer tolerate the pain (pain tolerance) or until the end of the testing (truncated at 300 seconds for safety purposes).
Reported as the mean (time to hand removal in seconds) at the 30 minute time point.
|
8 sessions over 4-6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Threshold
Time Frame: 8 sessions over 4-6 weeks
|
The amount of time (in seconds) before the participant first verbally reports feeling pain after placing hand in 4 degree Celsius circulating water bath at the 30 minute time point.
Truncated at 300 seconds for safety purposes.
|
8 sessions over 4-6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: David A Tompkins, M.D., Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Actual)
May 1, 2010
Study Completion (Actual)
May 1, 2010
Study Registration Dates
First Submitted
October 7, 2009
First Submitted That Met QC Criteria
October 7, 2009
First Posted (Estimate)
October 8, 2009
Study Record Updates
Last Update Posted (Actual)
October 6, 2017
Last Update Submitted That Met QC Criteria
September 7, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Neurologic Manifestations
- Sensation Disorders
- Somatosensory Disorders
- Hyperalgesia
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Antiemetics
- Gastrointestinal Agents
- Dermatologic Agents
- Analgesics, Opioid
- Narcotics
- Hypnotics and Sedatives
- Anesthetics, Local
- Anti-Allergic Agents
- Sleep Aids, Pharmaceutical
- Histamine H1 Antagonists
- Histamine Antagonists
- Histamine Agents
- Antipruritics
- Diphenhydramine
- Promethazine
- Alfentanil
Other Study ID Numbers
- NA_00022154
- 1K24DA023186 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperalgesia
-
Second Affiliated Hospital, School of Medicine,...RecruitingPostoperative HyperalgesiaChina
-
Wonkwang University HospitalCompletedHyperalgesia, MechanicalKorea, Republic of
-
The Second Affiliated Hospital of Chongqing Medical...CompletedPostoperative HyperalgesiaChina
-
University of WashingtonCompletedHyperalgesia, SecondaryUnited States, Brazil
-
National Institute on Drug Abuse (NIDA)Unknown
-
Ullevaal University HospitalUniversity of Oslo; Rikshospitalet University HospitalCompleted
-
Cambridge University Hospitals NHS Foundation TrustWithdrawn
-
University Hospital, Basel, SwitzerlandCompletedPain Perception | Secondary HyperalgesiaSwitzerland
-
Rigshospitalet, DenmarkCompleted
-
University of California, Los AngelesCompletedOpioid-Induced HyperalgesiaUnited States
Clinical Trials on Alfentanil
-
Region Örebro CountyCompletedLower Esophageal SphincterSweden
-
Stefanie SeifertCompletedPain | Patient SatisfactionSweden
-
University Hospital, GhentWithdrawn
-
Nigde Omer Halisdemir UniversityCompletedAnalgesia | Anesthesia
-
Tianjin Nankai HospitalRecruiting
-
University of MalayaMalaysian Society of AnaesthesiologistsCompleted
-
Hennepin Healthcare Research InstituteCompleted
-
Region Jönköping CountyRegion ÖstergötlandRecruitingPain | Cancer | Patient Satisfaction | Venous PunctureSweden
-
Oslo University HospitalUniversity Hospital, AkerCompletedAnesthesia Intubation ComplicationNorway
-
Second Affiliated Hospital, School of Medicine,...RecruitingTranscatheter Aortic Valve Replacement | General Anesthesia | Hemodynamics | Post-induction HypotensionChina